Vision2Voice Joins PAO Action Week™ to Support Patient Advocacy

Vision2Voice (V2V) is proud to participate in Patient Advocacy Organization (PAO) Action Week™ from June 9–13.

Founded by Astellas Pharma Inc., PAO Action Week celebrates the vital work of Patient Advocacy Organizations—more than 1,200 U.S. nonprofits that amplify the voices, needs, and rights of patients, particularly those living with serious illnesses. Now in its second year, PAO Action Week aims to raise awareness of the support, resources, and access to treatments and research that PAOs offer patients and caregivers.

“From day one, patients have been at the center of everything we do at V2V,” said Daniel Rehal, president and founder. “Supporting PAO Action Week aligns with our mission—it’s a powerful reminder that patients deserve the best care possible. This initiative reinforces the importance of advocacy in driving meaningful change in patient care.”

At V2V, improving patient lives is more than a goal; it’s our purpose. Together, we can make a meaningful difference—one person at a time. To learn more about PAO Action Week, including how to connect with a Patient Advocacy Organization, visit paoactionweek.com.

Recent Posts

Crowd of KOLs and DOLs

DOLs: A New Frontier

Whether you call them Key Opinion Leaders (KOLs) or Key External Experts (KEEs), success in the pharmaceutical space has always started with one essential task:...

Read More
Scientist in googles

Industry Happenings – October 2026

Learn how major industry trends are influencing the future of biopharma, including patent expiration challenges, evolving regulatory pathways, and emerging therapeutic targets that are attracting...

Read More
Story 2

Industry Happenings -September 2026

FDA policy, shifting R&D priorities, and heightened oversight of overseas trials are shaping the future of drug development. Don’t miss the latest in BioPharma! Source:...

Read More